International Journal of Rheumatic Diseases

The official journal of APLAR is now available on your iPad and iPhone. “International Journal of Rheumatic Diseases” brings you a stimulating, high-impact mixture of Invited Reviews, Original Articles, Novel Hypothesis, APLAR Grand Round Cases, Correspondences and more. Enjoy an entirely new browsing and reading experience, and keep up to date with the most important developments in rheumatology research even faster:

- Stay current with the latest articles through Early View
- Be notified when a new issue is available.
- Download articles and issues for offline perusal.
- Save your favorite articles for quick and easy access.
- Share articles with colleagues or students.

International Journal of Rheumatic Diseases is the official journal of the Asia Pacific League of Associations for Rheumatology and is published four times per year. The Journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders.

CURRENT SUBSCRIBERS to International Journal of Rheumatic Diseases can “pair” their device with their personal or institutional subscription to enjoy full access in this iPad edition.

SUBSCRIBE IN THE APP: Annual Subscriptions (6 issues) for the iPad-only edition are available for $199.99 (US) per year. Payment is charged to your iTunes account after confirmation of purchase. International Journal of Rheumatic Diseases subscriptions automatically renew within 24 hours of the end of your subscription period for $199.99 (US) unless auto-renew is turned off at least 24 hours before the end of the subscription period. To turn off auto-renew, go to your iTunes account settings after purchase. Note that subscriptions cannot be cancelled during the term of the subscription, but you can still turn off auto-renew to prevent automatic renewal of your subscription. Note that any unused portion of a free trial period, if offered, will be forfeited when you purchases a subscription.